Leef Brands (LEEEF) Notes Payables (2024 - 2026)

Leef Brands (LEEEF) reported Notes Payables of $864557.0 for Q1 2026, down 13.66% sequentially from $1.0 million in Q4 2025.

Leef Brands (LEEEF) Notes Payables (2024 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 3 years of Notes Payables data on file, last reported at $864557.0 in Q1 2026.

  • For the quarter ending Q1 2026, Notes Payables changed N/A year-over-year to $864557.0; the trailing twelve-month figure through Mar 2026 stood at $864557.0 (changed N/A YoY), and the FY2025 full-year result was $1.0 million, down 25.13% from the prior year.
  • Notes Payables slipped to $864557.0 in Q1 2026, from $1.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.3 million in Q4 2024 to a low of $864557.0 in Q1 2026.
  • A 3-year average of $1.1 million and a median of $1.0 million in 2025 frame the typical range for Notes Payables.
  • Peak annual rise in Notes Payables reached 25.13% in 2025, while the deepest fall reached 25.13% in 2025.
  • Tracing LEEEF's Notes Payables over 3 years: stood at $1.3 million in 2024, then fell by 25.13% to $1.0 million in 2025, then fell by 13.66% to $864557.0 in 2026.
  • Business Quant data shows LEEEF's Notes Payables at $864557.0 in Q1 2026, $1.0 million in Q4 2025, and $1.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 864,557.00
Dec 31, 2025 1.00 Mn
Dec 31, 2024 1.34 Mn